Status:
COMPLETED
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
Lead Sponsor:
AstraZeneca
Conditions:
GERD
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to assess the impact of abdominal fat on severity and frequency of GERD symptoms .
Eligibility Criteria
Inclusion
- Male or female \> or = 18 years old
- Patient with symptomatic GERD
- Without PPI or H2 antagonist treatment during the 3 previous months
- Agree to take part in this study
Exclusion
- Pregnant women
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
5084 Patients enrolled
Trial Details
Trial ID
NCT00695838
Start Date
January 1 2008
End Date
December 1 2008
Last Update
August 6 2009
Active Locations (1624)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Ablon-sur-Seine, France
2
Research Site
Achenheim, France
3
Research Site
Afa, France
4
Research Site
Agde, France